
Swedish biopharma Anocca has raised approximately ยฃ32m (SEK 440m) to support the early-stage clinical development of VIDAR-1, its lead TCR-T …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

